What is the current market price of the domestic version of serputinib/serpatinib?

The domestic version of Selpercatinib (Selpercatinib), as a new type of targeted therapy, has been launched in China, but it has not yet been included in the medical insurance catalog. This means that patients are responsible for the entire cost of purchasing the drug. According to the current market conditions, domestically produced Seputinib is mainly available in the specifications of 80mg*56 capsules. Each box is expected to sell for more than RMB 10,000, which is relatively expensive.

In contrast, the price of the original drug Seputinib in overseas markets is generally higher, usually ranging from 20,000 to more than 100,000 yuan. The specific price is greatly affected by exchange rate changes. The high price has become a financial burden for some patients to use this drug, especially during long-term treatment. The continuous expenditure of drug costs prohibits many patients.

In order to reduce the financial pressure on patients, generic versions of seputinib have gradually appeared in overseas markets in recent years. These generic drugs are basically the same as the original drugs in terms of ingredients and therapeutic effects, but are significantly cheaper. For example, the 40mg*120 generic drug produced by a Lao pharmaceutical factory sells for about more than 2,000 yuan, making it an affordable alternative for patients to purchase seputinib.

Generally speaking, although the domestically produced seputinib is already on the market, its price is still relatively high because it is not included in medical insurance. If patients have limited financial conditions, they may consider purchasing more affordable overseas generic drugs through formal channels. But no matter which version you choose, you should conduct it under the guidance of a professional doctor before use to ensure the safety and effectiveness of the treatment.

Reference materials:https://en.wikipedia.org/wiki/Selpercatinib